Center for Device Innovation

Accelerating development of breakthrough medical devices
Center for Device Innovation
About Us

Accelerating Innovation

The Center for Device Innovation at Texas Medical Center (CDI @ TMC) was founded in 2017 with the mission to significantly impact healthcare by accelerating the development of breakthrough medical technologies.  As a collaboration between Johnson & Johnson Medical Devices Companies, Johnson & Johnson Innovation, and the Texas Medical Center, CDI @ TMC is a unique hybrid model for innovation that leverages the great resources of these larger enterprises, but with the speed and agility of an entrepreneurial start-up environment.  The focus is on early-stage concepts with high technical risk, rapidly developing and testing new devices to prove feasibility with faster timelines and capital efficiency.  Technologies that have been successfully de-risked can move into a commercialization pathway within Johnson & Johnson or spin out into a new company.



​Facilities & Resources

  • 25,000 sq. ft. maker space designed for device development
  • Full machine shop with advanced prototyping equipment
  • 60 work benches with private access configurations
  • Separate lab / office space for companies in residence
  • Dedicated labs for tissue testing, chemistry and electronics / mechanical testing
  • 12 private offices and 24 open workstations
  • VR system and visualization space
  • 2 conference rooms
  • Café space

Hybrid Approach

Text left


Development projects led by CDI team

Text right


Seed-stage start-ups supported by CDI

CDI @ TMC has a hybrid portfolio that includes both internal technology projects as well as start-up companies in residence.  The development team has flexibility to engage in new opportunities across a spectrum of different services and needs, including: independent development, collaborative co-development, machining / prototyping services, pre-clinical testing, manufacturing design, and strategic advising.  The current portfolio includes a broad range of initiatives across various clinical spaces and technology platforms aligned with J&J’s medical device areas of interest:

Text left

- cardiovascular (atrial fibrillation)

- neurovascular (stroke)

- oncology (lung cancer)

- orthopedics (osteoarthritis / osteoporosis)

Text right

- general and minimally invasive surgery

- robotics and digital surgery

- obesity / bariatrics

- vision care

Investment Criteria

CDI is always looking for new opportunities to fill development pipeline. The main criteria for evaluating any new IDEA:

IMPACT - significant value proposition for patients / healthcare and market opportunity

DIFFERENTIATION - potential advantages of technology and IP relative to competition

ENGAGEMENT - good utilization of the resources and development capabilities at CDI

ALIGNMENT - clear fit with J&J's areas of interest and longer-term strategy


CDI @ TMC has a dynamic team with a proven track record of success in the medical device industry, and a wide range of expertise and capabilities for front-end development.

Texas Medical Center

The Texas Medical Center is the largest medical complex in the world, with 60+ member institutions and over 106,000 employees on a 50 million sq. ft. campus.  Each year, the TMC has more 10 million total patient visits, 750,000 ER visits, and 180,000 surgical procedures performed.  With these expansive resources in such proximity, CDI @ TMC has access to a broad range of pre-clinical and clinical facilities for testing and feedback to accelerate development.  CDI @ TMC has established partnerships with several institutions to leverage these resources of the Houston ecosystem.


Johnson & Johnson Innovation Announces New Collaboration with Texas Me...

Medical Device Entrepreneur Billy Cohn, M.D. to Lead Johnson & Johnson Innovation's new Center for Device Innovation.

Johnson & Johnson Innovation LLC (JJI) today announced the creation of the Center for Device Innovation at Texas Medical Center (CDI @ TMC), a broad, new collaboration between JJI and TMC that aims to accelerate end-to-end development of breakthrough medical devices. This expands on JJI's collaboration with TMC established earlier this year with the opening of JLABS @ TMC, combining the resources of the world's largest medical complex with the capabilities of the Johnson & Johnson Medical Devices Companies*, to advance the health and well-being of people around the globe...

Johnson & Johnson, Texas Medical Center join forces to develop medical...

Johnson & Johnson Innovation announced Tuesday that it has created the Center for Device Innovation at Texas Medical Center to speed up development of "breakthrough" medical devices.

CDI will consist of a new medical device engineering studio with a staff of researchers and developers, and will have access to preclinical facilities at the Baylor College of Medicine, Houston Methodist Research Institute and Texas Heart Institute, according to a statement from Johnson & Johnson...

J&J to create new Texas center to develop ‘breakthrough’ med tech

Johnson & Johnson ($JNJ) is pulling out all the stops in its efforts to turn around its medical devices business. After a restructuring early this year, the J&J medical device business actually grew--albeit only by 0.7%--to $6.2 billion last quarter.

The pharma's arm that invests in new technology, Johnson & Johnson Innovation (JJI), is doing its bit to try to help encourage the success of those efforts in the long term. It’s creating the new Center for Device Innovation at the Texas Medical Center (TMC) in Houston, which is intended to enable the entire process of creating “breakthrough” medical devices, the company said...

Contact Us

Make the Connection

For media inquiries, please contact:
Allie McCormick

For potential collaborations, please contact:
Joanna Nathan

Type of organization

Tour Information

Purpose / interest (check all that apply)
Requests need to be submitted at least 2 days in advance to accommodate scheduling.
Preferred date timing
Requests need to be submitted at least 2 days in advance to accommodate scheduling.
Alternate date timing